GBGB9614022.3A
GB9614022D0
(en)
|
1996-07-04 |
1996-07-04 |
Antiviral therapeutic combinations
|
PL97330747A
PL330747A1
(en)
|
1996-06-25 |
1997-06-23 |
Vx478, zidovudin, ftc and/or 3tc containing combinations for use in treating hiv infections
|
CZ984294A
CZ429498A3
(en)
|
1996-06-25 |
1997-06-23 |
Combination containing vx478, zidovudine, gtc and/or 3tc for treating hiv infection
|
ARP970102758A
AR007616A1
(en)
|
1996-06-25 |
1997-06-23 |
ANTIVIRAL COMBINATIONS
|
AU32627/97A
AU727983B2
(en)
|
1996-06-25 |
1997-06-23 |
Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatment of HIV
|
PCT/EP1997/003247
WO1997049411A1
(en)
|
1996-06-25 |
1997-06-23 |
Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
|
KR1019980710646A
KR20000022226A
(en)
|
1996-06-25 |
1997-06-23 |
Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
|
US09/202,660
US6544961B1
(en)
|
1996-06-25 |
1997-06-23 |
Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatments of HIV
|
CA002258956A
CA2258956A1
(en)
|
1996-06-25 |
1997-06-23 |
Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
|
IL12735197A
IL127351A0
(en)
|
1996-06-25 |
1997-06-23 |
Combinations comprising VX478 zidovudine FTC and/or 3TC for use in the treatment of HIV
|
NZ333099A
NZ333099A
(en)
|
1996-06-25 |
1997-06-23 |
synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV
|
TR1998/02704T
TR199802704T2
(en)
|
1996-06-25 |
1997-06-23 |
Use of combinations containing Vx478, Zidovidin, FTC and/or 3TC in the treatment of HIV.
|
JP10502320A
JP2000515852A
(en)
|
1996-06-25 |
1997-06-23 |
A combination comprising VX478, zidovudine, FTC and / or 3TC for use in treating HIV
|
HU9903249A
HUP9903249A3
(en)
|
1996-06-25 |
1997-06-23 |
Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
|
EP97928263A
EP0938321B1
(en)
|
1996-06-25 |
1997-06-23 |
Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv
|
BR9709939A
BR9709939A
(en)
|
1996-06-25 |
1997-06-23 |
Combination pharmaceutical formulation process for treating an HIV infection in an infected animal uses 3s acid tetrahydro-3-furanyl ester [3r * (1r *, 2s *)] - [- 3 - [[4-amino-phenyl) sulfonyl] (2-methylpropyl) -amino] -2-hydroxy-1-phenylmethyl) propyl] -carbamic zidovudine and (2r, cis) -4-amino-1- (2-hydroxymethyl-1,3-oxathiolan -5-il) - (1h) -pyrimidin-2-one and patient package
|
EA199801045A
EA001517B1
(en)
|
1996-06-25 |
1997-06-23 |
Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
|
ES97928263T
ES2213217T3
(en)
|
1996-06-25 |
1997-06-23 |
COMBINATIONS THAT INCLUDE VX478, ZIDOVUDINA, AND 3TC FOR USE IN THE TREATMENT OF HIV INFECTIONS.
|
APAP/P/1998/001419A
AP9801419A0
(en)
|
1996-06-25 |
1997-06-23 |
Combination comprising VX478, zidovudine, FTC and or 3
|
AT97928263T
ATE257708T1
(en)
|
1996-06-25 |
1997-06-23 |
COMBINATIONS CONTAINING VX478, ZIDOVUDINE AND 3TC FOR THE TREATMENT OF HIV
|
DE69727240T
DE69727240T2
(en)
|
1996-06-25 |
1997-06-23 |
Combinations containing VX478, zidovudine and 3TC for the treatment of HIV
|
PE00053497A
PE87298A1
(en)
|
1996-06-25 |
1997-06-23 |
ANTIVIRAL COMBINATIONS
|
IDP972147A
ID19490A
(en)
|
1996-06-25 |
1997-06-23 |
ANTIVIRAL COMBINATIONS
|
CO97034781A
CO4900074A1
(en)
|
1996-06-25 |
1997-06-23 |
ANTIVIRAL COMBINATIONS
|
CN97197357A
CN1228026A
(en)
|
1996-06-25 |
1997-06-23 |
Combinations comprising VX 478, zidovudine, FTC and/or 3TC for use in treatment of HIV
|
TW086111193A
TW469132B
(en)
|
1996-06-25 |
1997-08-05 |
Antiviral combinations
|
IS4915A
IS4915A
(en)
|
1996-06-25 |
1998-11-30 |
Compositions containing VX478, Zidovudine, FTC and / or 3TC for use in the treatment of HIV
|
YU58398A
YU58398A
(en)
|
1996-06-25 |
1998-12-16 |
Combinations comprising vx478, zidovudine, ftc and/or 3tc for use the terapy of hiv
|
NO986034A
NO986034L
(en)
|
1996-06-25 |
1998-12-22 |
Combinations comprising VX 478, ZidovudÞn, FTC and / or 3TC for use in the treatment of HIV
|